The International Generic and Biosimilar Medicines Association has announced the appointment of Vivian Frittelli, CEO of Generic and Biosimilar Medicines of Southern Africa, as its chair for 2022. Additionally, Jonathan Kimball, vice president of trade and international affairs at the US Association for Accessible Medicines and vice chair of the IGBA International Trade and Intellectual Property Committee, has been appointed as IGBA vice chair.
Frittelli takes over from Sudarshan Jain, secretary general of the Indian Pharmaceutical Alliance, who acted as chair during 2021. (Also see "Who’s Hired
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?